Revvity RVTY
NYSE RVTY
$148.85 -5.54 (-3.59%)
At close: Nov 16, 2026 · 4:00 PM EST

Revvity (RVTY) Current Deferred Revenue (2010 - 2016)

Updated

Revvity (RVTY) recorded Current Deferred Revenue of $163.17 million in Q4 2016.

Analysis

Revvity (RVTY) Current Deferred Revenue (2010 - 2016) Analysis & Trends

  • Across earlier years, Current Deferred Revenue came in at $168.93 million in FY2014.
  • The Q4 2016 figure is the lowest quarterly Current Deferred Revenue since Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 255.60 Bn 232.12 Bn 5.13 Bn
2 Abbott Laboratories 186.63 Bn 160.49 Bn 7.39 Bn
3 Danaher 162.01 Bn 141.66 Bn 3.84 Bn
4 Intuitive Surgical 152.73 Bn 133.02 Bn 2.08 Bn
5 Medtronic 132.05 Bn 97.30 Bn 6.34 Bn
6 Stryker 118.57 Bn 104.75 Bn 4.25 Bn
7 Boston Scientific 63.47 Bn 58.91 Bn 3.43 Bn
8 Edwards Lifesciences 61.58 Bn 44.79 Bn 1.35 Bn
9 Agilent Technologies 48.77 Bn 41.66 Bn 1.04 Bn
10 Revvity 16.64 Bn 13.24 Bn 418.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jan 3, 2016 163.17 Mn
Dec 28, 2014 168.93 Mn
Jan 3, 2010 20.26 Mn
API Access

Revvity Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RVTY&period=max&api_key=YOUR_API_KEY